{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:27:34Z","timestamp":1760909254445},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T00:00:00Z","timestamp":1619049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T00:00:00Z","timestamp":1619049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We evaluate the risks of various urological disorders that require treatments according to obesity and metabolic health status using a nationwide dataset of the Korean population. 3,969,788 patients who had undergone health examinations were enrolled. Participants were classified as \u201cobese\u201d (O) or \u201cnon-obese\u201d (NO) using a BMI cut-off of 25\u00a0kg\/m2. People who developed\u2009\u2265\u20091 metabolic disease component in the index year were considered \u201cmetabolically unhealthy\u201d (MU), while those with none were considered \u201cmetabolically healthy\u201d (MH). There were classified into the MHNO, MUNO, MHO, and MUO group. In BPH, chronic renal disease, neurogenic bladder, any medication related to voiding dysfunction, alpha-blocker, and antidiuretics, age and gender-adjusted hazard ratio (HR) was highest in MUO, but higher in MUNO than in MHO. In stress incontinence, prostate surgery, and 5alpha-reductase, HR increased in the order of MUNO, MHO, and MUO. In prostatitis, anti-incontinence surgery, and cystocele repair, HR was higher in MHO than MUNO and MUO. In cystitis, cystostomy, and anticholinergics, HR was higher in MUNO and MUO than MHO. In conclusion, obesity and metabolic health were individually or collaboratively involved in urological disorders related to voiding dysfunction. Metabolic healthy obesity needs to be distinguished in the diagnosis and treatment of urological disorders.<\/jats:p>","DOI":"10.1038\/s41598-021-88165-z","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T10:10:11Z","timestamp":1619086211000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Obesity, metabolic health, and urological disorders in adults: a nationwide population-based study"],"prefix":"10.1038","volume":"11","author":[{"given":"Jong Keun","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Goo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyungdo","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Hyun","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,22]]},"reference":[{"key":"88165_CR1","doi-asserted-by":"publisher","first-page":"943162","DOI":"10.1155\/2014\/943162","volume":"2014","author":"J Kaur","year":"2014","unstructured":"Kaur, J. A comprehensive review on metabolic syndrome. Cardiol. Res. Pract. 2014, 943162. https:\/\/doi.org\/10.1155\/2014\/943162 (2014).","journal-title":"Cardiol. Res. Pract."},{"key":"88165_CR2","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/j.juro.2012.09.064","volume":"188","author":"V Kupelian","year":"2012","unstructured":"Kupelian, V. Nocturia, sleep disturbance and the metabolic syndrome. J. Urol. 188, 2041\u20132042. https:\/\/doi.org\/10.1016\/j.juro.2012.09.064 (2012).","journal-title":"J. Urol."},{"key":"88165_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.juro.2013.07.011","volume":"191","author":"AB Araujo","year":"2014","unstructured":"Araujo, A. B. et al. Sleep related problems and urological symptoms: testing the hypothesis of bidirectionality in a longitudinal, population based study. J. Urol. 191, 100\u2013106. https:\/\/doi.org\/10.1016\/j.juro.2013.07.011 (2014).","journal-title":"J. Urol."},{"key":"88165_CR4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/nau.22765","volume":"35","author":"MA Denys","year":"2016","unstructured":"Denys, M. A., Anding, R., Tubaro, A., Abrams, P. & Everaert, K. Lower urinary tract symptoms and metabolic disorders: ICI-RS 2014. Neurourol. Urodyn. 35, 278\u2013282. https:\/\/doi.org\/10.1002\/nau.22765 (2016).","journal-title":"Neurourol. Urodyn."},{"key":"88165_CR5","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/sj.ijo.0802881","volume":"29","author":"S Rohrmann","year":"2005","unstructured":"Rohrmann, S., Smit, E., Giovannucci, E. & Platz, E. A. Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III). Int. J. Obes. (Lond) 29, 310\u2013316. https:\/\/doi.org\/10.1038\/sj.ijo.0802881 (2005).","journal-title":"Int. J. Obes. (Lond)"},{"key":"88165_CR6","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.juro.2013.08.110","volume":"191","author":"AM Mondul","year":"2014","unstructured":"Mondul, A. M., Giovannucci, E. & Platz, E. A. A prospective study of obesity, and the incidence and progression of lower urinary tract symptoms. J. Urol. 191, 715\u2013721. https:\/\/doi.org\/10.1016\/j.juro.2013.08.110 (2014).","journal-title":"J. Urol."},{"key":"88165_CR7","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1097\/01.ju.0000136255.83054.0c","volume":"172","author":"WC Lee","year":"2004","unstructured":"Lee, W. C. et al. Effects of diabetes on female voiding behavior. J. Urol. 172, 989\u2013992. https:\/\/doi.org\/10.1097\/01.ju.0000136255.83054.0c (2004).","journal-title":"J. Urol."},{"key":"88165_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/bf00184112","volume":"12","author":"S Mommsen","year":"1994","unstructured":"Mommsen, S. & Foldspang, A. Body mass index and adult female urinary incontinence. World J. Urol. 12, 319\u2013322. https:\/\/doi.org\/10.1007\/bf00184112 (1994).","journal-title":"World J. Urol."},{"key":"88165_CR9","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1186\/1471-2458-11-754","volume":"11","author":"P Pajunen","year":"2011","unstructured":"Pajunen, P. et al. Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey. BMC Public Health 11, 754. https:\/\/doi.org\/10.1186\/1471-2458-11-754 (2011).","journal-title":"BMC Public Health"},{"key":"88165_CR10","doi-asserted-by":"publisher","first-page":"30329","DOI":"10.1038\/srep30329","volume":"6","author":"HK Yang","year":"2016","unstructured":"Yang, H. K. et al. Obesity, metabolic health, and mortality in adults: A nationwide population-based study in Korea. Sci. Rep. 6, 30329. https:\/\/doi.org\/10.1038\/srep30329 (2016).","journal-title":"Sci. Rep."},{"key":"88165_CR11","first-page":"280","volume":"18","author":"K Lee","year":"2009","unstructured":"Lee, K. Metabolically obese but normal weight (MONW) and metabolically healthy but obese (MHO) phenotypes in Koreans: Characteristics and health behaviors. Asia Pac. J. Clin. Nutr. 18, 280\u2013284 (2009).","journal-title":"Asia Pac. J. Clin. Nutr."},{"key":"88165_CR12","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.2337\/diacare.28.7.1769","volume":"28","author":"ES Ford","year":"2005","unstructured":"Ford, E. S. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: A summary of the evidence. Diabetes Care 28, 1769\u20131778. https:\/\/doi.org\/10.2337\/diacare.28.7.1769 (2005).","journal-title":"Diabetes Care"},{"key":"88165_CR13","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.eururo.2011.08.012","volume":"60","author":"CJ Keto","year":"2011","unstructured":"Keto, C. J., Masko, E. M. & Freedland, S. J. Physical activity, obesity, and lower urinary tract symptoms. Eur. Urol. 60, 1181\u20131183. https:\/\/doi.org\/10.1016\/j.eururo.2011.08.012 (2011) (discussion 1183).","journal-title":"Eur. Urol."},{"key":"88165_CR14","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/aje\/kwh060","volume":"159","author":"S Rohrmann","year":"2004","unstructured":"Rohrmann, S., Smit, E., Giovannucci, E. & Platz, E. A. Associations of obesity with lower urinary tract symptoms and noncancer prostate surgery in the Third National Health and Nutrition Examination Survey. Am. J. Epidemiol. 159, 390\u2013397. https:\/\/doi.org\/10.1093\/aje\/kwh060 (2004).","journal-title":"Am. J. Epidemiol."},{"key":"88165_CR15","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1016\/j.juro.2009.07.086","volume":"182","author":"JK Parsons","year":"2009","unstructured":"Parsons, J. K., Sarma, A. V., McVary, K. & Wei, J. T. Obesity and benign prostatic hyperplasia: Clinical connections, emerging etiological paradigms and future directions. J. Urol. 182, S27-31. https:\/\/doi.org\/10.1016\/j.juro.2009.07.086 (2009).","journal-title":"J. Urol."},{"key":"88165_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/bju.12728","volume":"115","author":"M Gacci","year":"2015","unstructured":"Gacci, M. et al. Metabolic syndrome and benign prostatic enlargement: A systematic review and meta-analysis. BJU Int. 115, 24\u201331. https:\/\/doi.org\/10.1111\/bju.12728 (2015).","journal-title":"BJU Int."},{"key":"88165_CR17","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0022-5347(05)64687-3","volume":"168","author":"SE Dahle","year":"2002","unstructured":"Dahle, S. E. et al. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J. Urol. 168, 599\u2013604 (2002).","journal-title":"J. Urol."},{"key":"88165_CR18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.eururo.2006.05.040","volume":"51","author":"C Ozden","year":"2007","unstructured":"Ozden, C. et al. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Eur Urol 51, 199\u2013203. https:\/\/doi.org\/10.1016\/j.eururo.2006.05.040 (2007) (discussion 204-196).","journal-title":"Eur Urol"},{"key":"88165_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/sj.pcan.4500221","volume":"1","author":"J Hammarsten","year":"1998","unstructured":"Hammarsten, J., Hogstedt, B., Holthuis, N. & Mellstrom, D. Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis. 1, 157\u2013162. https:\/\/doi.org\/10.1038\/sj.pcan.4500221 (1998).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"88165_CR20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/ijcp.12518","volume":"69","author":"F Bunn","year":"2015","unstructured":"Bunn, F. et al. Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studies. Int. J. Clin. Pract. 69, 199\u2013217. https:\/\/doi.org\/10.1111\/ijcp.12518 (2015).","journal-title":"Int. J. Clin. Pract."},{"key":"88165_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/MOU.0b013e3283336f3f","volume":"20","author":"S Moul","year":"2010","unstructured":"Moul, S. & McVary, K. T. Lower urinary tract symptoms, obesity and the metabolic syndrome. Curr. Opin. Urol. 20, 7\u201312. https:\/\/doi.org\/10.1097\/MOU.0b013e3283336f3f (2010).","journal-title":"Curr. Opin. Urol."},{"key":"88165_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.7326\/0003-4819-140-3-200402030-00007","volume":"140","author":"J Chen","year":"2004","unstructured":"Chen, J. et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann. Intern. Med. 140, 167\u2013174. https:\/\/doi.org\/10.7326\/0003-4819-140-3-200402030-00007 (2004).","journal-title":"Ann. Intern. Med."},{"key":"88165_CR23","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/sj.sc.3101729","volume":"43","author":"E Garshick","year":"2005","unstructured":"Garshick, E. et al. A prospective assessment of mortality in chronic spinal cord injury. Spinal Cord 43, 408\u2013416. https:\/\/doi.org\/10.1038\/sj.sc.3101729 (2005).","journal-title":"Spinal Cord"},{"key":"88165_CR24","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.urology.2011.09.040","volume":"79","author":"MJ Semins","year":"2012","unstructured":"Semins, M. J., Shore, A. D., Makary, M. A., Weiner, J. & Matlaga, B. R. The impact of obesity on urinary tract infection risk. Urology 79, 266\u2013269. https:\/\/doi.org\/10.1016\/j.urology.2011.09.040 (2012).","journal-title":"Urology"},{"key":"88165_CR25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ejim.2012.11.006","volume":"24","author":"W Saliba","year":"2013","unstructured":"Saliba, W., Barnett-Griness, O. & Rennert, G. The association between obesity and urinary tract infection. Eur. J. Intern. Med. 24, 127\u2013131. https:\/\/doi.org\/10.1016\/j.ejim.2012.11.006 (2013).","journal-title":"Eur. J. Intern. Med."},{"key":"88165_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11934-018-0762-7","volume":"19","author":"A Fuselier","year":"2018","unstructured":"Fuselier, A., Hanberry, J., Margaret Lovin, J. & Gomelsky, A. Obesity and stress urinary incontinence: Impact on pathophysiology and treatment. Curr. Urol. Rep. 19, 10. https:\/\/doi.org\/10.1007\/s11934-018-0762-7 (2018).","journal-title":"Curr. Urol. Rep."},{"key":"88165_CR27","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/MOU.0000000000000428","volume":"27","author":"UJ Lee","year":"2017","unstructured":"Lee, U. J., Kerkhof, M. H., van Leijsen, S. A. & Heesakkers, J. P. Obesity and pelvic organ prolapse. Curr. Opin. Urol. 27, 428\u2013434. https:\/\/doi.org\/10.1097\/MOU.0000000000000428 (2017).","journal-title":"Curr. Opin. Urol."},{"key":"88165_CR28","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.juro.2015.05.100","volume":"194","author":"R Zhang","year":"2015","unstructured":"Zhang, R. et al. Lifestyle and risk of chronic prostatitis\/chronic pelvic pain syndrome in a cohort of United States male health professionals. J. Urol. 194, 1295\u20131300. https:\/\/doi.org\/10.1016\/j.juro.2015.05.100 (2015).","journal-title":"J. Urol."},{"key":"88165_CR29","doi-asserted-by":"publisher","first-page":"395","DOI":"10.4093\/dmj.2014.38.5.395","volume":"38","author":"SO Song","year":"2014","unstructured":"Song, S. O. et al. Background and data configuration process of a nationwide population-based study using the Korean national health insurance system. Diabetes Metab. J. 38, 395\u2013403. https:\/\/doi.org\/10.4093\/dmj.2014.38.5.395 (2014).","journal-title":"Diabetes Metab. J."},{"key":"88165_CR30","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1093\/ije\/dyv319","volume":"46","author":"J Lee","year":"2017","unstructured":"Lee, J., Lee, J. S., Park, S. H., Shin, S. A. & Kim, K. Cohort profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int. J. Epidemiol. 46, e15. https:\/\/doi.org\/10.1093\/ije\/dyv319 (2017).","journal-title":"Int. J. Epidemiol."},{"key":"88165_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4093\/dmj.2016.40.1.79","volume":"40","author":"YH Lee","year":"2016","unstructured":"Lee, Y. H. et al. Data analytic process of a nationwide population-based study using national health information database established by National Health Insurance Service. Diabetes Metab. J. 40, 79\u201382. https:\/\/doi.org\/10.4093\/dmj.2016.40.1.79 (2016).","journal-title":"Diabetes Metab. J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88165-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88165-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88165-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T07:06:15Z","timestamp":1670051175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88165-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,22]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["88165"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-88165-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,22]]},"assertion":[{"value":"21 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8687"}}